Stay updated on Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment status was updated to indicate no further participant enrollment, and new navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added along with a formatting change to the Intervention/Treatment heading and a revision update (v3.6.0).SummaryDifference0.4%

- Check21 days agoChange DetectedRevision: v3.5.5 replaces v3.5.4. This appears to be a page version update, not a change to the study content.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page footer revision tag was updated from v3.5.3 to v3.5.4. This signals a newer build of the page.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page’s footer/version indicator has been updated from revision v3.5.2 to v3.5.3, reflecting a site software or release change rather than an update to the clinical trial information.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check99 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.